Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now small index

Cardiogenic Shock, ECMO clinical trials

1 of 1 indexed Cardiogenic Shock, ECMO trials are currently recruiting.

Corpus placement: #11,370 of 28,707 conditions by registered trial count.

1 US clinical trials · 1 currently recruiting · #11,370 of 28,707 conditions by registered trial count

Cardiogenic Shock, ECMO: 1 US clinical trial tracked, 1 recruiting.

Cardiogenic Shock, ECMO is the subject of 1 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. The most active sponsor is Atlantic Health System, running 1 of these trials.

Enrollment posture brief

Registry condition cardiogenic-shock-ecmo

OPEN 1 | RECR 100% | LATE 0 | EARLY 0 | RANK #11370 | SPON 1

Nearest open-share peer: Aortic Arch Aneurysm (100% recruiting · 5 trials)

Cardiogenic Shock, ECMO (thi…100%Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%
Open-enrollment share among volume-matched conditions near Cardiogenic Shock, ECMO

Cardiogenic Shock, ECMO lists 1 open slots (100% of 1 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cardiogenic Shock, ECMO on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cardiogenic Shock, ECMO is recruiting above its size-band peers.

    1 of 1 indexed trials (100%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Cardiogenic Shock, ECMO records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Left Atrial Veno-Arterial Extracorporeal Membrane Oxygenation (LAVA-ECMO) Device
1 trials

US sites by state

Facility locations filed on Cardiogenic Shock, ECMO trials. A trial with sites in several states counts in each.

New Jersey 1 trials
Michigan 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cardiogenic Shock, ECMO page

1 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cardiogenic Shock, ECMO condition card totals 1 registered trials; most-linked intervention Left Atrial Veno-Arterial Extracorporeal Membrane Oxygenation (LAVA-ECMO); top US site state New Jersey. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.